Aya Takahashi
Kyoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Real-world outcomes of molecular targeted agents for patients with hepatocellular carcinoma over 80 years old.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: February 09, 2022
Hepatitis C virus eradication prolongs overall survival in hepatocellular carcinoma patients receiving molecular-targeted agents.
Journal: Journal of gastroenterology
Published: September 26, 2021
Re-administration of nivolumab after immune checkpoint inhibitor-induced cholangitis: the first reported case.
Journal: Clinical journal of gastroenterology
Published: September 15, 2021
Enhanced Antitumor Effect in Liver Cancer by Amino Acid Depletion-Induced Oxidative Stress.
Journal: Frontiers in oncology
Published: August 14, 2021
Tyrosine Kinase Inhibitors Stimulate HLA Class I Expression by Augmenting the IFNγ/STAT1 Signaling in Hepatocellular Carcinoma Cells.
Journal: Frontiers in oncology
Published: May 10, 2021
Hepatocyte-specific fibroblast growth factor 21 overexpression ameliorates high-fat diet-induced obesity and liver steatosis in mice.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: May 01, 2021
The Effect of Genetic Polymorphism in Response to Body Weight Reduction in Japanese Patients with Nonalcoholic Fatty Liver Disease.
Journal: Genes
Published: March 06, 2021
The Appropriate Opportunity for Evaluating Liver Fibrosis by Using the FIB-4 Index in Patients with Nonalcoholic Fatty Liver Disease in Japan.
Journal: Diagnostics (Basel, Switzerland)
Published: September 02, 2020
The Association between the Platelet Count and Liver Volume in Compensated Cirrhosis Patients after the Eradication of Hepatitis C virus by Direct-acting Antivirals.
Journal: Internal medicine (Tokyo, Japan)
Published: August 04, 2020
Effect of pemafibrate on fatty acid levels and liver enzymes in non-alcoholic fatty liver disease patients with dyslipidemia: A single-arm, pilot study.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: June 24, 2020
PPARα agonist and metformin co-treatment ameliorates NASH in mice induced by a choline-deficient, amino acid-defined diet with 45% fat.
Journal: Scientific reports
Published: May 22, 2020
Last Updated: 09/26/2026